235
Views
24
CrossRef citations to date
0
Altmetric
Original Articles

Garcinia mangostana: a source of potential anti-cancer lead compounds against CEM-SS cell line

, , &
Pages 475-479 | Received 08 Oct 2007, Accepted 08 Jan 2008, Published online: 27 Jul 2010
 

Abstract

Our current interest in searching for natural anti-cancer lead compounds from plants has led us to the discovery that the stem and roots of Garcinia mangostana can be a source of such compounds. The stem furnished 2,8-dihydroxy-6-methoxy-5-(3-methylbut-2-enyl)-xanthone (1), which is a new xanthone. Meanwhile, the root bark of the plant furnished six xanthones, namely α-mangostin (2), β-mangostin (3), γ-mangostin (4), garcinone D (5), mangostanol (6), and gartanin (7). The hexane and chloroform extracts of the root bark of G. mangostana as well as the hexane extract of the stem bark were found to be active against the CEM-SS cell line. γ-Mangostin (4) showed good activity with a very low IC50 value of 4.7 μg/ml, while α-mangostin (2), mangostanol (6), and garcinone D (5) showed significant activities with IC50 values of 5.5, 9.6, and 3.2 μg/ml, respectively. This is the first report on the cytotoxicity of the extracts of the stem and root bark of G. mangostana and of α-mangostin, mangostanol, and garcinone D against the CEM-SS cell line.

Acknowledgements

The authors thank the Malaysian IRPA grant for the financial support and Mr Johadi Iskandar of Chemistry Department, UPM, for recording the NMR spectra.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.